Detalles de la búsqueda
1.
The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19.
Trials;
23(1): 158, 2022 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35172891
2.
Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib study.
CPT Pharmacometrics Syst Pharmacol;
10(12): 1497-1511, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34608769
Resultados
1 -
2
de 2
1
Próxima >
>>